ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Therapeutic anticoagulation in COVID-19 patients [Carta] (2021)
Lemos, Anna Cristina Bertoldi; Espírito Santo, Douglas Alexandre do; Miranda, Carlos Henrique
Source: Thrombosis Research. Unidade: FMRP
Subjects: ANTICOAGULANTES, COAGULAÇÃO SANGUÍNEA, TROMBOEMBOLISMO, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, Anna Cristina Bertoldi e ESPÍRITO SANTO, Douglas Alexandre do e MIRANDA, Carlos Henrique. Therapeutic anticoagulation in COVID-19 patients [Carta]. Thrombosis Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.thromres.2021.04.027. Acesso em: 18 fev. 2026. , 2021
APA
Lemos, A. C. B., Espírito Santo, D. A. do, & Miranda, C. H. (2021). Therapeutic anticoagulation in COVID-19 patients [Carta]. Thrombosis Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.thromres.2021.04.027
NLM
Lemos ACB, Espírito Santo DA do, Miranda CH. Therapeutic anticoagulation in COVID-19 patients [Carta] [Internet]. Thrombosis Research. 2021 ; 203 72-73.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2021.04.027
Vancouver
Lemos ACB, Espírito Santo DA do, Miranda CH. Therapeutic anticoagulation in COVID-19 patients [Carta] [Internet]. Thrombosis Research. 2021 ; 203 72-73.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2021.04.027
Artigo de periodico
Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) (2020)
Lemos, Anna Cristina Bertoldi; Espírito Santo, Douglas Alexandre do; Salvetti, Maísa Cabetti; Gilio, Renato Noffs; Agra, Lucas Barbosa; Pazin Filho, Antonio; Miranda, Carlos Henrique
Source: Thrombosis Research. Unidade: FMRP
Subjects: RESPIRAÇÃO ARTIFICIAL, ANTICOAGULANTES, TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, Anna Cristina Bertoldi et al. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thrombosis Research, v. 196, p. 359-366, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2020.09.026. Acesso em: 18 fev. 2026.
APA
Lemos, A. C. B., Espírito Santo, D. A. do, Salvetti, M. C., Gilio, R. N., Agra, L. B., Pazin Filho, A., & Miranda, C. H. (2020). Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thrombosis Research, 196, 359-366. doi:10.1016/j.thromres.2020.09.026
NLM
Lemos ACB, Espírito Santo DA do, Salvetti MC, Gilio RN, Agra LB, Pazin Filho A, Miranda CH. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) [Internet]. Thrombosis Research. 2020 ; 196 359-366.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2020.09.026
Vancouver
Lemos ACB, Espírito Santo DA do, Salvetti MC, Gilio RN, Agra LB, Pazin Filho A, Miranda CH. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) [Internet]. Thrombosis Research. 2020 ; 196 359-366.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2020.09.026
Artigo de periodico
Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts (2020)
Rocha, Amanda Leal; Bighetti-Trevisan, Rayana Longo ; Duffles, Leticia Fernanda; Arruda, José Alcides Almeida de; Taira, Thaise Mayumi ; Assis, Bruna Rodrigues Dias; Macari, Soraia ; Diniz, Ivana Márcia Alves; Beloti, Márcio Mateus ; Rosa, Adalberto Luiz ; Fukada, Sandra Yasuyo ; Goulart, Gisele Assis Castro; Ribeiro, Daniel Dias; Abreu, Lucas Guimarães; Silva, Tarcília Aparecida
Source: Thrombosis Research. Unidades: FORP, FCFRP, FMRP
Subjects: ANTICOAGULANTES, OSTEOCLASTO, OSTEOBLASTO, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Amanda Leal et al. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts. Thrombosis Research, v. 186, p. 45-53, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2019.12.014. Acesso em: 18 fev. 2026.
APA
Rocha, A. L., Bighetti-Trevisan, R. L., Duffles, L. F., Arruda, J. A. A. de, Taira, T. M., Assis, B. R. D., et al. (2020). Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts. Thrombosis Research, 186, 45-53. doi:10.1016/j.thromres.2019.12.014
NLM
Rocha AL, Bighetti-Trevisan RL, Duffles LF, Arruda JAA de, Taira TM, Assis BRD, Macari S, Diniz IMA, Beloti MM, Rosa AL, Fukada SY, Goulart GAC, Ribeiro DD, Abreu LG, Silva TA. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts [Internet]. Thrombosis Research. 2020 ; 186 45-53.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2019.12.014
Vancouver
Rocha AL, Bighetti-Trevisan RL, Duffles LF, Arruda JAA de, Taira TM, Assis BRD, Macari S, Diniz IMA, Beloti MM, Rosa AL, Fukada SY, Goulart GAC, Ribeiro DD, Abreu LG, Silva TA. Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts [Internet]. Thrombosis Research. 2020 ; 186 45-53.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2019.12.014
Artigo de periodico
Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial (2014)
Yamaguti, Erciliene M. M.; Brito, Milena B.; Ferriani, Rui Alberto; Garcia, Andréa A.; Rosa e Silva, Júlio César; Vieira, Carolina Sales
Source: Thrombosis Research. Unidade: FMRP
Subjects: ENDOMETRIOSE (TRATAMENTO), COAGULAÇÃO SANGUÍNEA (EFEITOS DE DROGAS), DISPOSITIVOS INTRAUTERINOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMAGUTI, Erciliene M. M. et al. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial. Thrombosis Research, v. 134, n. 6, p. 1193-1197, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2014.09.014. Acesso em: 18 fev. 2026.
APA
Yamaguti, E. M. M., Brito, M. B., Ferriani, R. A., Garcia, A. A., Rosa e Silva, J. C., & Vieira, C. S. (2014). Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial. Thrombosis Research, 134( 6), 1193-1197. doi:10.1016/j.thromres.2014.09.014
NLM
Yamaguti EMM, Brito MB, Ferriani RA, Garcia AA, Rosa e Silva JC, Vieira CS. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial [Internet]. Thrombosis Research. 2014 ; 134( 6): 1193-1197.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2014.09.014
Vancouver
Yamaguti EMM, Brito MB, Ferriani RA, Garcia AA, Rosa e Silva JC, Vieira CS. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial [Internet]. Thrombosis Research. 2014 ; 134( 6): 1193-1197.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2014.09.014
Artigo de periodico
The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption (2013)
Sousa-Santos, Ozelia; Neto-Neves, Evandro M.; Ferraz, Karina C.; Sertório, Jonas T.; Portella, Rafael L.; Tanus-Santos, José Eduardo
Source: Thrombosis Research. Unidade: FMRP
Subjects: ANTIOXIDANTES (APLICAÇÕES TERAPÊUTICAS), HEMODINÂMICA (EFEITOS DE DROGAS), ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, EMBOLIA PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA-SANTOS, Ozelia et al. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption. Thrombosis Research, v. 132, n. 5, p. 578-583, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2013.09.014. Acesso em: 18 fev. 2026.
APA
Sousa-Santos, O., Neto-Neves, E. M., Ferraz, K. C., Sertório, J. T., Portella, R. L., & Tanus-Santos, J. E. (2013). The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption. Thrombosis Research, 132( 5), 578-583. doi:10.1016/j.thromres.2013.09.014
NLM
Sousa-Santos O, Neto-Neves EM, Ferraz KC, Sertório JT, Portella RL, Tanus-Santos JE. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption [Internet]. Thrombosis Research. 2013 ; 132( 5): 578-583.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2013.09.014
Vancouver
Sousa-Santos O, Neto-Neves EM, Ferraz KC, Sertório JT, Portella RL, Tanus-Santos JE. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption [Internet]. Thrombosis Research. 2013 ; 132( 5): 578-583.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2013.09.014
Artigo de periodico
Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial (2012)
Brito, Milena B.; Ferriani, Rui Alberto; Meijers, Joost C. M.; Garcia, Andréa A.; Quintana, Silvana Maria; Sá, Marcos Felipe Silva de; Vieira, Carolina Sales
Source: Thrombosis Research. Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, PERÍODO PERINATAL, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Milena B. et al. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial. Thrombosis Research, v. 130, n. 3, p. 355-360, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2012.03.029. Acesso em: 18 fev. 2026.
APA
Brito, M. B., Ferriani, R. A., Meijers, J. C. M., Garcia, A. A., Quintana, S. M., Sá, M. F. S. de, & Vieira, C. S. (2012). Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial. Thrombosis Research, 130( 3), 355-360. doi:10.1016/j.thromres.2012.03.029
NLM
Brito MB, Ferriani RA, Meijers JCM, Garcia AA, Quintana SM, Sá MFS de, Vieira CS. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial [Internet]. Thrombosis Research. 2012 ; 130( 3): 355-360.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2012.03.029
Vancouver
Brito MB, Ferriani RA, Meijers JCM, Garcia AA, Quintana SM, Sá MFS de, Vieira CS. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial [Internet]. Thrombosis Research. 2012 ; 130( 3): 355-360.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2012.03.029
Artigo de periodico
Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease (2010)
Schettert, Isolmar T.; Pereira, Alexandre C.; Lopes, Neuza H.; Hueb, Whady A.; Krieger, José Eduardo
Source: Thrombosis Research. Unidade: FM
Subjects: CORONARIOPATIA, POLIMORFISMO, DOENÇA DE VON WILLEBRAND, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHETTERT, Isolmar T. et al. Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease. Thrombosis Research, v. 125, n. 1, p. 61-66, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2009.03.008. Acesso em: 18 fev. 2026.
APA
Schettert, I. T., Pereira, A. C., Lopes, N. H., Hueb, W. A., & Krieger, J. E. (2010). Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease. Thrombosis Research, 125( 1), 61-66. doi:10.1016/j.thromres.2009.03.008
NLM
Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE. Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease [Internet]. Thrombosis Research. 2010 ; 125( 1): 61-66.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2009.03.008
Vancouver
Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE. Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease [Internet]. Thrombosis Research. 2010 ; 125( 1): 61-66.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2009.03.008
Artigo de periodico
Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism (2010)
Mühl, Diána; Ghosh, Subhamay; Uzuelli, Juliana A.; Lantos, János; Tanus-Santos, José Eduardo
Source: Thrombosis Research. Unidade: FMRP
Subjects: EMBOLIA PULMONAR, FIBRINÓLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MÜHL, Diána et al. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, v. 125, n. 6, p. 549-553, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2010.02.015. Acesso em: 18 fev. 2026.
APA
Mühl, D., Ghosh, S., Uzuelli, J. A., Lantos, J., & Tanus-Santos, J. E. (2010). Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, 125( 6), 549-553. doi:10.1016/j.thromres.2010.02.015
NLM
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015
Vancouver
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015
Artigo de periodico
Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress (2009)
Dias-Júnior, Carlos A.; Cau, Stefany B. A.; Oliveira, Alisson M.; Castro, Michele M.; Montenegro, Marcelo F.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Thrombosis Research. Unidades: FORP, FMRP
Subjects: EMBOLIA, METALOPROTEINASES, ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIAS-JÚNIOR, Carlos A. et al. Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. Thrombosis Research, v. 124, n. 3, p. 349-355, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2008.12.006. Acesso em: 18 fev. 2026.
APA
Dias-Júnior, C. A., Cau, S. B. A., Oliveira, A. M., Castro, M. M., Montenegro, M. F., Gerlach, R. F., & Tanus-Santos, J. E. (2009). Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. Thrombosis Research, 124( 3), 349-355. doi:10.1016/j.thromres.2008.12.006
NLM
Dias-Júnior CA, Cau SBA, Oliveira AM, Castro MM, Montenegro MF, Gerlach RF, Tanus-Santos JE. Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress [Internet]. Thrombosis Research. 2009 ; 124( 3): 349-355.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2008.12.006
Vancouver
Dias-Júnior CA, Cau SBA, Oliveira AM, Castro MM, Montenegro MF, Gerlach RF, Tanus-Santos JE. Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress [Internet]. Thrombosis Research. 2009 ; 124( 3): 349-355.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2008.12.006
Artigo de periodico
A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study) (2007)
Pereira, Ana C.; Lourenço, Dayse M.; Maffei, Francisco H.; Morelli, Vânia M.; Rollo, Hamilton A.; Zago, Marco Antonio; Vannucchi, Hélio; Franco, Rendrik F.
Source: Thrombosis Research. Unidade: FMRP
Subjects: POLIMORFISMO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Ana C. et al. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study). Thrombosis Research, v. 119, n. 2, p. 183-188, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2006.01.008. Acesso em: 18 fev. 2026.
APA
Pereira, A. C., Lourenço, D. M., Maffei, F. H., Morelli, V. M., Rollo, H. A., Zago, M. A., et al. (2007). A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study). Thrombosis Research, 119( 2), 183-188. doi:10.1016/j.thromres.2006.01.008
NLM
Pereira AC, Lourenço DM, Maffei FH, Morelli VM, Rollo HA, Zago MA, Vannucchi H, Franco RF. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study) [Internet]. Thrombosis Research. 2007 ; 119( 2): 183-188.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2006.01.008
Vancouver
Pereira AC, Lourenço DM, Maffei FH, Morelli VM, Rollo HA, Zago MA, Vannucchi H, Franco RF. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study) [Internet]. Thrombosis Research. 2007 ; 119( 2): 183-188.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2006.01.008
Artigo de periodico
Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study) (2007)
Pieroni, Fabiano; Lourenço, Dayse M.; Morelli, Vânia M.; Maffei, Francisco H.; Zago, Marco Antônio; Franco, Rendrik França
Source: Thrombosis Research. Unidade: FMRP
Subjects: TROMBOSE, VEIAS, COAGULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIERONI, Fabiano et al. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thrombosis Research, v. 120, n. 2, p. 221-229, 2007Tradução . . Acesso em: 18 fev. 2026.
APA
Pieroni, F., Lourenço, D. M., Morelli, V. M., Maffei, F. H., Zago, M. A., & Franco, R. F. (2007). Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thrombosis Research, 120( 2), 221-229.
NLM
Pieroni F, Lourenço DM, Morelli VM, Maffei FH, Zago MA, Franco RF. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thrombosis Research. 2007 ; 120( 2): 221-229.[citado 2026 fev. 18 ]
Vancouver
Pieroni F, Lourenço DM, Morelli VM, Maffei FH, Zago MA, Franco RF. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thrombosis Research. 2007 ; 120( 2): 221-229.[citado 2026 fev. 18 ]
Trabalho de evento-resumo periodico
Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris (2007)
Lobo, Tatiana Correa Carneiro; Konig, Sandra; Sogayar, Mari Cleide ; Francischetti, I. M. B.; Monteiro, Robson de Queiroz
Source: Thrombosis Research. Conference titles: International Conference on Thrombosis and Hemostasis Issues in Cancer. Unidade: IQ
Subjects: ANTICOAGULANTES, ANTINEOPLÁSICOS, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOBO, Tatiana Correa Carneiro et al. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. Oxford: Instituto de Química, Universidade de São Paulo. . Acesso em: 18 fev. 2026. , 2007
APA
Lobo, T. C. C., Konig, S., Sogayar, M. C., Francischetti, I. M. B., & Monteiro, R. de Q. (2007). Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. Oxford: Instituto de Química, Universidade de São Paulo.
NLM
Lobo TCC, Konig S, Sogayar MC, Francischetti IMB, Monteiro R de Q. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. 2007 ; 120 S165 res. PO-62.[citado 2026 fev. 18 ]
Vancouver
Lobo TCC, Konig S, Sogayar MC, Francischetti IMB, Monteiro R de Q. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. 2007 ; 120 S165 res. PO-62.[citado 2026 fev. 18 ]
Artigo de periodico
Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children (2007)
Alésio, Ana C. M.; Höehr, Nelci F.; Siqueira, Lúcia H.; Bydlowski, Sérgio P.; Annichino-Bizzacchi, Joyce M.
Source: Thrombosis Research. Unidade: FM
Subjects: POLIMORFISMO, GENES, CRIANÇAS, GENÓTIPOS (ENZIMOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALÉSIO, Ana C. M. et al. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children. Thrombosis Research, n. 5, p. 571-577, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2006.05.009. Acesso em: 18 fev. 2026.
APA
Alésio, A. C. M., Höehr, N. F., Siqueira, L. H., Bydlowski, S. P., & Annichino-Bizzacchi, J. M. (2007). Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children. Thrombosis Research, ( 5), 571-577. doi:10.1016/j.thromres.2006.05.009
NLM
Alésio ACM, Höehr NF, Siqueira LH, Bydlowski SP, Annichino-Bizzacchi JM. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children [Internet]. Thrombosis Research. 2007 ;( 5): 571-577.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2006.05.009
Vancouver
Alésio ACM, Höehr NF, Siqueira LH, Bydlowski SP, Annichino-Bizzacchi JM. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children [Internet]. Thrombosis Research. 2007 ;( 5): 571-577.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2006.05.009
Artigo de periodico
The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes (2007)
Fürstenau, Cristina R.; Trentin, Danielle S.; Barreto-Chaves, Maria Luiza Morais ; Sarkis, João J. F.
Source: Thrombosis Research. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FÜRSTENAU, Cristina R. et al. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes. Thrombosis Research, v. 120, n. 6, p. 877-884, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2007.01.006. Acesso em: 18 fev. 2026.
APA
Fürstenau, C. R., Trentin, D. S., Barreto-Chaves, M. L. M., & Sarkis, J. J. F. (2007). The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes. Thrombosis Research, 120( 6), 877-884. doi:10.1016/j.thromres.2007.01.006
NLM
Fürstenau CR, Trentin DS, Barreto-Chaves MLM, Sarkis JJF. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes [Internet]. Thrombosis Research. 2007 ; 120( 6): 877-884.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2007.01.006
Vancouver
Fürstenau CR, Trentin DS, Barreto-Chaves MLM, Sarkis JJF. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes [Internet]. Thrombosis Research. 2007 ; 120( 6): 877-884.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2007.01.006
Trabalho de evento-resumo periodico
Malignant transformation in melanocytes increases the production of procoagulant microvesicles (2007)
Lima, L. G.; Barcinski, Marcello André; Monteiro, R. Q.
Source: Thrombosis Research. Conference titles: International Conference on Thrombosis and Hemostasis Issues in Cancer. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, L. G. e BARCINSKI, Marcello André e MONTEIRO, R. Q. Malignant transformation in melanocytes increases the production of procoagulant microvesicles. Thrombosis Research. Elmsford: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 18 fev. 2026. , 2007
APA
Lima, L. G., Barcinski, M. A., & Monteiro, R. Q. (2007). Malignant transformation in melanocytes increases the production of procoagulant microvesicles. Thrombosis Research. Elmsford: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Lima LG, Barcinski MA, Monteiro RQ. Malignant transformation in melanocytes increases the production of procoagulant microvesicles. Thrombosis Research. 2007 ; 120[citado 2026 fev. 18 ]
Vancouver
Lima LG, Barcinski MA, Monteiro RQ. Malignant transformation in melanocytes increases the production of procoagulant microvesicles. Thrombosis Research. 2007 ; 120[citado 2026 fev. 18 ]
Artigo de periodico
Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization (2007)
Pereira, Alexandre C.; Miyakawa, Ayumi A.; Lopes, Neuza H. M.; Soares, Paulo R.; Oliveira, Sergio A. de; Cesar, Luiz A. M.; Ramires, José A. F.; Hueb, Whady; Krieger, José Eduardo
Source: Thrombosis Research. Unidade: FM
Subjects: CORONARIOPATIA (MORTALIDADE;COMPLICAÇÕES), REVASCULARIZAÇÃO MIOCÁRDICA (EFEITOS ADVERSOS), GENÓTIPOS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Alexandre C. et al. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization. Thrombosis Research, v. 121, n. 1, p. 25-32, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2007.03.004. Acesso em: 18 fev. 2026.
APA
Pereira, A. C., Miyakawa, A. A., Lopes, N. H. M., Soares, P. R., Oliveira, S. A. de, Cesar, L. A. M., et al. (2007). Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization. Thrombosis Research, 121( 1), 25-32. doi:10.1016/j.thromres.2007.03.004
NLM
Pereira AC, Miyakawa AA, Lopes NHM, Soares PR, Oliveira SA de, Cesar LAM, Ramires JAF, Hueb W, Krieger JE. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization [Internet]. Thrombosis Research. 2007 ; 121( 1): 25-32.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2007.03.004
Vancouver
Pereira AC, Miyakawa AA, Lopes NHM, Soares PR, Oliveira SA de, Cesar LAM, Ramires JAF, Hueb W, Krieger JE. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization [Internet]. Thrombosis Research. 2007 ; 121( 1): 25-32.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2007.03.004
Artigo de periodico
Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease (2006)
Schettert, Isolmar T.; Pereira, Alexandre C.; Lopes, Neuza H.; Hueb, Whady A.; Krieger, José Eduardo
Source: Thrombosis Research. Unidade: FM
Subjects: CORONARIOPATIA, DOENÇA CRÔNICA, FATORES DE RISCO, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHETTERT, Isolmar T. et al. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease. Thrombosis Research, v. 118, p. 679-683, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2005.11.009. Acesso em: 18 fev. 2026.
APA
Schettert, I. T., Pereira, A. C., Lopes, N. H., Hueb, W. A., & Krieger, J. E. (2006). Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease. Thrombosis Research, 118, 679-683. doi:10.1016/j.thromres.2005.11.009
NLM
Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease [Internet]. Thrombosis Research. 2006 ; 118 679-683.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2005.11.009
Vancouver
Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease [Internet]. Thrombosis Research. 2006 ; 118 679-683.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2005.11.009
Artigo de periodico
Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia (2006)
Nasser, M.; Wolosker, Nelson; Uint, L.; Rosoky, R. A.; Lobato, M.; Wajgarten, M.; Leao, Pedro Puech
Source: Thrombosis Research. Unidade: FM
Subjects: TROMBOEMBOLISMO, ISQUEMIA (COMPLICAÇÕES), DOENÇAS VASCULARES (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSER, M. et al. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia. Thrombosis Research, v. 117, p. 271-277, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2005.03.010. Acesso em: 18 fev. 2026.
APA
Nasser, M., Wolosker, N., Uint, L., Rosoky, R. A., Lobato, M., Wajgarten, M., & Leao, P. P. (2006). Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia. Thrombosis Research, 117, 271-277. doi:10.1016/j.thromres.2005.03.010
NLM
Nasser M, Wolosker N, Uint L, Rosoky RA, Lobato M, Wajgarten M, Leao PP. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia [Internet]. Thrombosis Research. 2006 ; 117 271-277.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2005.03.010
Vancouver
Nasser M, Wolosker N, Uint L, Rosoky RA, Lobato M, Wajgarten M, Leao PP. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia [Internet]. Thrombosis Research. 2006 ; 117 271-277.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.thromres.2005.03.010
Artigo de periodico
Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis (2003)
Ramacciotti, Eduardo; Wolosker, Nelson; Puech-Leao, Pedro; Zeratti, Eduardo Antônio; Gusson, Paula Regina; Giglio, Auro del; Franco, Rendrik F.
Source: Thrombosis Research. Unidade: FM
Subjects: POLIMORFISMO, TROMBOSE, NEOPLASIAS (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMACCIOTTI, Eduardo et al. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis. Thrombosis Research, v. 109, p. 171-174, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0049-3848(03)00179-8. Acesso em: 18 fev. 2026.
APA
Ramacciotti, E., Wolosker, N., Puech-Leao, P., Zeratti, E. A., Gusson, P. R., Giglio, A. del, & Franco, R. F. (2003). Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis. Thrombosis Research, 109, 171-174. doi:10.1016/s0049-3848(03)00179-8
NLM
Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, Giglio A del, Franco RF. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis [Internet]. Thrombosis Research. 2003 ; 109 171-174.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/s0049-3848(03)00179-8
Vancouver
Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, Giglio A del, Franco RF. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis [Internet]. Thrombosis Research. 2003 ; 109 171-174.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/s0049-3848(03)00179-8
Artigo de periodico
In vivo characterization of lopap, a prothrombin activator serine protease from the lonomia obliqua caterpillar venom (2001)
Reis, Cleison V; Farsky, Sandra Helena Poliselli ; Fernandes, Beatriz Lieblich; Santoro, M L; Oliva, Maria L V; Mariano, Mário; Camargo, Antonio C M; Chudzinski-Tavassi, Ana M
Source: Thrombosis Research. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, Cleison V et al. In vivo characterization of lopap, a prothrombin activator serine protease from the lonomia obliqua caterpillar venom. Thrombosis Research, v. 102, p. 437-443, 2001Tradução . . Acesso em: 18 fev. 2026.
APA
Reis, C. V., Farsky, S. H. P., Fernandes, B. L., Santoro, M. L., Oliva, M. L. V., Mariano, M., et al. (2001). In vivo characterization of lopap, a prothrombin activator serine protease from the lonomia obliqua caterpillar venom. Thrombosis Research, 102, 437-443.
NLM
Reis CV, Farsky SHP, Fernandes BL, Santoro ML, Oliva MLV, Mariano M, Camargo ACM, Chudzinski-Tavassi AM. In vivo characterization of lopap, a prothrombin activator serine protease from the lonomia obliqua caterpillar venom. Thrombosis Research. 2001 ;102 437-443.[citado 2026 fev. 18 ]
Vancouver
Reis CV, Farsky SHP, Fernandes BL, Santoro ML, Oliva MLV, Mariano M, Camargo ACM, Chudzinski-Tavassi AM. In vivo characterization of lopap, a prothrombin activator serine protease from the lonomia obliqua caterpillar venom. Thrombosis Research. 2001 ;102 437-443.[citado 2026 fev. 18 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Normalized affiliation

Non normalized affiliation